Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

NETWORK 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Rhabdomyosarcoma 8Wilms Tumor 6Sarcoma 6Malignant mesenchymal tumor 4Rhabdomyosarcoma, Embryonal 2Kidney Neoplasms 2Hydatidiform Mole 2Stage I Mixed Cell Type Kidney Wilms Tumor 1Sarcoma, Ewing 1Rhabdomyosarcoma, Alveolar 1Pleuropulmonary blastoma 1Gestational Trophoblastic Disease 1Fibrosarcoma 1Choriocarcinoma 1Carcinoma, Renal Cell 1Beckwith-Wiedemann Syndrome 1

Interventions

Vincristine 2Radiotherapy 2Radiation 2Magnetic Resonance Spectroscopy 2Dactinomycin 2Cyclophosphamide 2Biopsy 2X-Rays 1Vinorelbine 1Specimen Handling 1Phantoms, Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Rhabdomyosarcoma, Embryonal × Dactinomycin × Clear all
NCT04994132 2026-05-05

A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma

Children's Oncology Group

Phase 3 Active not recruiting
118 enrolled
Sarcoma

Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal

NCT05304585 2026-05-05

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

Children's Oncology Group

Phase 3 Recruiting
205 enrolled
Sarcoma

Rhabdomyosarcoma, Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡